Current Report Filing (8-k)
February 05 2016 - 03:41PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) February 5, 2016
MEDIFIRST
SOLUTIONS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
333-178825 |
|
27-3888260 |
State
or other jurisdiction
incorporation |
|
Commission
File Number |
|
IRS
Employer
Identification No. |
4400
Route 9 South, Suite 1000, Freehold, NJ |
|
07728 |
(Address
of principal executive offices) |
|
(Zip
Code) |
Registrant's telephone number, including
area code: (732)-786-8044
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section
7- Regulation FD
Item
7.01 Regulation FD Disclosure
The
Company announces that its Premarket Notification 510(k) submission to the U.S. Food and Drug Administration for the Company’s
“The Time Machine” Series Laser is in final review. Further updated information will be available at the Company’s
website www.medifirstsolutions.com and in reports on Form 8-K.
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
MEDIFIRST SOLUTIONS, INC. |
|
|
|
Dated: February 5, 2016 |
by: |
/s/ Bruce Schoengood |
|
|
President and Chief Executive Officer |
2